Skip to main content
Clinical Trials/RBR-7xx7g7
RBR-7xx7g7
Completed
Phase 2

Evaluation of the effect of support therapies for Temporomandibular Disorders (TMD) about physical, psychosocial and related to sleep

niversidade Federal do Rio Grande do Norte0 sitesMarch 30, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Federal do Rio Grande do Norte
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 30, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal do Rio Grande do Norte

Eligibility Criteria

Inclusion Criteria

  • Patients with a positive diagnosis for TMD obtained through axis I of the RDC / TMD were included; those who underwent last treatment for TMD with a minimum interval of 3 (three) months; individuals with reports of pain in the orofacial region in the last 3 (three) months; patients aged 18 to 65 years.

Exclusion Criteria

  • Individuals with impaired cognitive ability who were unable to understand the questions in the questionnaires were excluded; those with a history of head trauma that is related to the etiology of orofacial pain and that can confuse the diagnosis of TMD; those with headaches or intracranial disorders; individuals who have used medications in the past 3 months that interfere with sleep quality such as muscle relaxants, anticonvulsants, antidepressants and anxiolytics; patients using medication to treat TMD or muscle pain; those who had other causes of orofacial pain such as caries, periodontal diseases, neuropathies and fibromyalgia; who had an insurmountable fear of a needle or bleeding disorders (only for the craniopuncture group).

Outcomes

Primary Outcomes

Not specified

Similar Trials